
Operating instructions
ECOM
ix
• Adjustment of blood or plasma and body temperature
Contraindication
• Hyperkalemia when using hemodialysis concentrate with a potassium content that is too high
• Hypokalemia when using hemodialysis concentrate with a potassium content that is too low
• Uncontrollable coagulation disorders
Adverse Effects
• Hemodialysis can cause side effects such as hypotension, nausea, vomiting and cramping.
The choice of an
ECOC
art and thus the selection of a suitable acidic dialysis concentrate is the
responsibility of the physician. Duration of treatment, frequency of treatment and dosage must be
determined by the attending physician.
ECOM
ix and
ECOC
art are not used directly on patients and are intended solely for
use by medical professionals. The concentrate produced by the
ECOM
ix is used to
produce dialysis fluid which is then used on patients. In case of adverse effects, the
patient should consult a physician.
1.5 Improper Use
The following uses and actions are considered improper:
• Changing the specifications such that the permitted limits are exceeded;
• Using components from other manufacturers that are not authorised by Intermedt;
• Non-compliance with the operating instructions;
• Operating the system with defective safety devices;
• Disabling or overriding the safety devices.
"
Caution
The security measures of the
ECOM
ix are only operational when the
system is turned on.
1.6 Installation
Assembly and installation of the
ECOM
ix system must exclusively be planned and performed by
technicians authorized by Intermedt. A separate manual for the installation is issued exclusively to
authorized technicians. The installation manual also details the requirements for the installation.
1.7 Maintenance
Maintenance of the
ECOM
ix system must exclusively be performed by technicians authorized by
Intermedt. For maintenance, there is a separate manual which is issued exclusively to authorized
technicians. Maintenance is required every 12 months.
State: April 2021
17
4.9.1., I Manual ECOMix Original (EN), 7, F: M. Lorek, 06.04.2021